Sai Life Sciences Soars on Market Debut with 39% Premium
Sai Life Sciences Ltd witnessed a robust debut on the stock market, closing with a 39% premium over its issue price. The company, valued at Rs 15,917.44 crore, attracted high trading volumes and plans to use proceeds for debt repayment and corporate purposes.
- Country:
- India
Sai Life Sciences Ltd experienced a stellar debut on the stock market, finishing Wednesday with a 39% premium over its issue price of Rs 549. The stock opened strong at Rs 660 on the BSE, eventually closing at Rs 765.30, a 39.39% increase.
On the NSE, the shares began trading at Rs 650 and closed at Rs 764.65, reflecting a commendable rise of 39.28%. The company's market capitalization stands at Rs 15,917.44 crore, with impressive trading volumes recorded across both stock exchanges.
The Hyderabad-based organization, known for its comprehensive services in drug discovery and development, plans to use a portion of the IPO proceeds for debt repayment. This IPO was oversubscribed 10.26 times, indicating strong market interest.
ALSO READ
-
Vietnam's Stock Market Set for Boost with FTSE Upgrade
-
Global Markets Rally as Central Banks Drive Economic Sentiment
-
Financial Turmoil in Turkey Sparks Government Intervention: What's Next?
-
FTSE 100 Climbs as Bank of England Holds Steady
-
Nigerian Fintech Overload: The Rush for Dangote Refinery Shares
Google News